Qiagen N.V. cash flow statement

In fiscal 2025, Qiagen N.V.'s operations generated $654m of cash; it spent $201m on capital projects, leaving free cash flow of $453m. It returned $54.2m in dividends and $280m through buybacks.

Cash flow statement

US$ millions unless shown otherwise. Fiscal years, plus the last twelve months (LTM) when newer.

Qiagen N.V.: cash flow statement, annual
Fiscal year	2009Dec 2009	2010Dec 2010	2011Dec 2011	2012Dec 2012	2013Dec 2013	2014Dec 2014	2015Dec 2015	2016Dec 2016	2017Dec 2017	2018Dec 2018	2019Dec 2019	2020Dec 2020	2021Dec 2021	2022Dec 2022	2023Dec 2023	2024Dec 2024	2025Dec 2025
Cash from operations	217	251	245	245	259	288	317	342	287	359	331	458	639	715	459	674	654
Depreciation and amortisation	49	143	167	198	199	201	191	213	216	206	231	205	215	208	205	203	194
Stock-based pay	10	14	20	25	38	41	24	28	34	40	66	41	38	50	47	44	50
Capital spending	52	80	87	102	84	87	98	75	90	110	118	133	190	129	150	167	201
Free cash flow	165	171	158	143	174	201	220	267	197	250	213	325	449	586	310	506	453
Free cash flow after stock pay	155	157	138	118	137	160	196	239	162	210	147	284	411	537	263	463	403
Dividends paid	—	—	—	—	—	—	—	—	—	—	—	—	—	—	0	0	54
Share buybacks	—	0	0	36	86	127	21	0	61	105	74	64	100	0	0	292	280
Shares issued	650	11	9	17	25	12	10	6	6	4	2	8	8	0	0	—	—

Free cash flow is cash from operations minus capital spending. Free cash flow after stock pay also subtracts stock-based compensation, a real cost to shareholders that the cash flow statement adds back. Dividends, buybacks and shares issued are cash amounts for the period.

Compare with peers

Head to head: BIO vs QGEN FTRE vs QGEN MEDP vs QGEN

More: Life Sciences Tools & Services stocks compared, Health Care sector, rankings of US companies

Figures from Qiagen N.V.'s SEC filings (10-K and 10-Q). How we read and check them: methodology and data sources. Not investment advice. Back to Qiagen N.V.